Method for generation of in vivo biotinylated recombinant antibodies by yeast mating

Journal of Immunological Methods

Volumn 317, Issue 1-2, 2006, Pages 132-143

  Scholler, Nathalie ^a   Garvik, Barbara ^a   Quarles, Travis ^b   Jiang, Shaoyi ^b   Urban, Nicole ^a  

^a Molecular Diagnostics Program   (United States)

^b University of Washington   (United States)

Author keywords

Antibody engineering; Biobody; In vivo biotinylation; Surface plasmon resonance sensor; Yeast display scFv; Yeast secreted proteins

Indexed keywords

BIOTIN HOLOENZYME SYNTHETASE; COMPLEMENTARY DNA; ENZYME; KEX2 PROTEASE; LIGASE; RECOMBINANT ANTIBODY; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUILIBRIUM CONSTANT; ESCHERICHIA COLI; FLOW CYTOMETRY; GOLGI COMPLEX; HAPLOIDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MATING; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; WESTERN BLOTTING; YEAST;

ANTIBODIES; ANTIBODY AFFINITY; BIOTINYLATION; BLOTTING, WESTERN; CELL LINE; EPIDIDYMAL SECRETORY PROTEINS; FLOW CYTOMETRY; HUMANS; RECOMBINANT FUSION PROTEINS; SURFACE PLASMON RESONANCE; TRANSFECTION; YEASTS;

EID: 33751420234     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.10.003     Document Type: Article

References (55)

1. Barker D.F., and Campbell A.M. The birA gene of Escherichia coli encodes a biotin holoenzyme synthetase. J. Mol. Biol. 146 (1981) 451
2. Barker D.F., and Campbell A.M. Genetic and biochemical characterization of the birA gene and its product: evidence for a direct role of biotin holoenzyme synthetase in repression of the biotin operon in Escherichia coli. J. Mol. Biol. 146 (1981) 469
3. Bayer E.A., and Wilchek M. Protein biotinylation. Methods Enzymol. 184 (1990) 138
4. Beckett D., Kovaleva E., and Schatz P.J. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci. 8 (1999) 921
5. Boozer C., Ladd J., Chen S., and Jiang S. DNA-directed protein immobilization for simultaneous detection of multiple analytes by surface plasmon resonance biosensor. Anal. Chem. 78 (2006) 1515
6. Brinkman B.M. Splice variants as cancer biomarkers. Clin. Biochem. 37 (2004) 584
7. Burbulis I., Yamaguchi K., Gordon A., Carlson R., and Brent R. Using protein-DNA chimeras to detect and count small numbers of molecules. Nat. Methods 2 (2005) 31
8. Carrette O., Demalte I., Scherl A., Yalkinoglu O., Corthals G., Burkhard P., Hochstrasser D.F., and Sanchez J.C. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 3 (2003) 1486
9. Chen D.S., Soen Y., Stuge T.B., Lee P.P., Weber J.S., Brown P.O., and Davis M.M. Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray. PLoS Med. 2 (2005) e265
10. Chubet R.G., and Brizzard B.L. Vectors for expression and secretion of FLAG epitope-tagged proteins in mammalian cells. BioTechniques 20 (1996) 136
11. Cloutier S.M., Couty S., Terskikh A., Marguerat L., Crivelli V., Pugnieres M., Mani J.C., Leisinger H.J., Mach J.P., and Deperthes D. Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Mol. Immunol. 37 (2000) 1067
12. Cronan Jr. J.E. Biotination of proteins in vivo. A post-translational modification to label, purify, and study proteins. J. Biol. Chem. 265 (1990) 10327
13. Etzioni R., Urban N., Ramsey S., McIntosh M., Schwartz S., Reid B., Radich J., Anderson G., and Hartwell L. The case for early detection. Nat. Rev., Cancer 3 (2003) 243
14. Feldhaus M.J., Siegel R.W., Opresko L.K., Coleman J.R., Feldhaus J.M., Yeung Y.A., Cochran J.R., Heinzelman P., Colby D., Swers J., Graff C., Wiley H.S., and Wittrup K.D. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat. Biotechnol. 21 (2003) 163
15. Fredriksson S., Gullberg M., Jarvius J., Olsson C., Pietras K., Gustafsdottir S.M., Ostman A., and Landegren U. Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20 (2002) 473
16. Fuller R.S., Brake A.J., and Thorner J. Intracellular targeting and structural conservation of a prohormone-processing endoprotease. Science 246 (1989) 482
17. Gao W.M., Kuick R., Orchekowski R.P., Misek D.E., Qiu J., Greenberg A.K., Rom W.N., Brenner D.E., Omenn G.S., Haab B.B., and Hanash S.M. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 5 (2005) 110
18. Gorelik E., Landsittel D.P., Marrangoni A.M., Modugno F., Velikokhatnaya L., Winans M.T., Bigbee W.L., Herberman R.B., and Lokshin A.E. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol. Biomark. Prev. 14 (2005) 981
19. Green N.M., and Melamed M.D. Optical rotatory dispersion, circular dichroism and far-ultraviolet spectra of avidin and streptavidin. Biochem. J. 100 (1966) 614
20. Hellstrom I., Raycraft J., Hayden-Ledbetter M., Ledbetter J.A., Schummer M., McIntosh M., Drescher C., Urban N., and Hellstrom K.E. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 63 (2003) 3695
21. Hoffman C.S., and Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57 (1987) 267
22. Homola J., Dostalek J., Chen S., Rasooly A., Jiang S., and Yee S.S. Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milk. Int. J. Food Microbiol. 75 (2002) 61
23. Howard P.K., Shaw J., and Otsuka A.J. Nucleotide sequence of the birA gene encoding the biotin operon repressor and biotin holoenzyme synthetase functions of Escherichia coli. Gene 35 (1985) 321
24. Kalnina Z., Zayakin P., Silina K., and Line A. Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 42 (2005) 342
25. Kipriyanov S.M., Little M., Kropshofer H., Breitling F., Gotter S., and Dubel S. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Protein Eng. 9 (1996) 203
26. Kittleson M.M., and Hare J.M. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Trends Cardiovasc. Med. 15 (2005) 130
27. Ladd J., Boozer C., Yu Q., Chen S., Homola J., and Jiang S. DNA-directed protein immobilization on mixed self-assembled monolayers via a streptavidin bridge. Langmuir 20 (2004) 8090
28. Mahlknecht U., and Hoelzer D. Histone acetylation modifiers in the pathogenesis of malignant disease. Mol. Med. 6 (2000) 623
29. Muhlrad D., Hunter R., and Parker R. A rapid method for localized mutagenesis of yeast genes. Yeast 8 (1992) 79
30. Mumberg D., Muller R., and Funk M. Regular promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res. 22 (1994) 5767
31. Myszka D.G., and Morton T.A. CLAMP: a biosensor kinetic data analysis program. Trends Biochem. Sci. 23 (1998) 149
32. Omenn G.S., States D.J., Adamski M., Blackwell T.W., Menon R., Hermjakob H., Apweiler R., Haab B.B., Simpson R.J., Eddes J.S., Kapp E.A., Moritz R.L., Chan D.W., Rai A.J., Admon A., Aebersold R., Eng J., Hancock W.S., Hefta S.A., Meyer H., Paik Y.K., Yoo J.S., Ping P., Pounds J., Adkins J., Qian X., Wang R., Wasinger V., Wu C.Y., Zhao X., Zeng R., Archakov A., Tsugita A., Beer I., Pandey A., Pisano M., Andrews P., Tammen H., Speicher D.W., and Hanash S.M. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 (2005) 3226
33. Ping P., Vondriska T.M., Creighton C.J., Gandhi T.K., Yang Z., Menon R., Kwon M.S., Cho S.Y., Drwal G., Kellmann M., Peri S., Suresh S., Gronborg M., Molina H., Chaerkady R., Rekha B., Shet A.S., Gerszten R.E., Wu H., Raftery M., Wasinger V., Schulz-Knappe P., Hanash S.M., Paik Y.K., Hancock W.S., States D.J., Omenn G.S., and Pandey A. A functional annotation of subproteomes in human plasma. Proteomics 5 (2005) 3506
34. Prince H.E. Biomarkers for diagnosing and monitoring autoimmune diseases. Biomarkers 10 Suppl 1 (2005) 44
35. Roelofsen H., Balgobind R., and Vonk R.J. Proteomic analyzes of copper metabolism in an in vitro model of Wilson disease using surface enhanced laser desorption/ionization-time of flight-mass spectrometry. J. Cell. Biochem. 93 (2004) 732
36. Samols D., Thornton C.G., Murtif V.L., Kumar G.K., Haase F.C., and Wood H.G. Evolutionary conservation among biotin enzymes. J. Biol. Chem. 263 (1988) 6461
37. Santala V., and Lamminmaki U. Production of a biotinylated single-chain antibody fragment in the cytoplasm of Escherichia coli. J. Immunol. Methods 284 (2004) 165
38. Santos-Rosa H., and Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer 41 (2005) 2381
39. Saviranta P., Haavisto T., Rappu P., Karp M., and Lovgren T. In vitro enzymatic biotinylation of recombinant Fab fragments through a peptide acceptor tail. Bioconjug. Chem. 9 (1998) 725
40. Schatz P.J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (N Y) 11 (1993) 1138
41. Scholler N., Crawford M., Sato A., Drescher C., O'Briant K., Kiviat N., Anderson G., and Urban N. Bead-based ELISA assays for validation of ovarian cancer early detection markers. Clin. Cancer Res. 12 (2006) 2117
42. Scholler, N., Garvik, B., Hayden-Ledbetter, M., Kline, T., Urban, N. in press. Development of a CA125-Mesothelin Cell Adhesion Assay as a Screening Tool for Biologics Discovery. Cancer Lett.
43. Schummer M., Ng W.V., Bumgarner R.E., Nelson P.S., Schummer B., Bednarski D.W., Hassell L., Baldwin R.L., Karlan B.Y., and Hood L. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene 238 (1999) 375
44. Schwegler E.E., Cazares L., Steel L.F., Adam B.L., Johnson D.A., Semmes O.J., Block T.M., Marrero J.A., and Drake R.R. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 41 (2005) 634
45. Sibler A.P., Kempf E., Glacet A., Orfanoudakis G., Bourel D., and Weiss E. In vivo biotinylated recombinant antibodies: high efficiency of labelling and application to the cloning of active anti-human IgG1 Fab fragments. J. Immunol. Methods 224 (1999) 129
46. Smith P.A., Tripp B.C., DiBlasio-Smith E.A., Lu Z., LaVallie E.R., and McCoy J.M. A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli. Nucleic Acids Res. 26 (1998) 1414
47. Sumiyama K., Saitou N., and Ueda S. Adaptive evolution of the IgA hinge region in primates. Mol. Biol. Evol. 19 (2002) 1093
48. Utz P.J. Protein arrays for studying blood cells and their secreted products. Immunol. Rev. 204 (2005) 264
49. Venables J.P. Aberrant and alternative splicing in cancer. Cancer Res. 64 (2004) 7647
50. Vignali D.A. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 243 (2000) 243
51. Wang X., Campoli M., Ko E., Luo W., and Ferrone S. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. J. Immunol. Methods 294 (2004) 23
52. Warren D.J., Bjerner J., Paus E., Bormer O.P., and Nustad K. Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies. Clin. Chem. 51 (2005) 830
53. Weaver-Feldhaus J.M., Miller K.D., Feldhaus M.J., and Siegel R.W. Directed evolution for the development of conformation-specific affinity reagents using yeast display. Protein Eng. Des. Sel. 18 (2005) 527
54. Wilcox C.A., Redding K., Wright R., and Fuller R.S. Mutation of a tyrosine localization signal in the cytosolic tail of yeast Kex2 protease disrupts Golgi retention and results in default transport to the vacuole. Mol. Biol. Cell 3 (1992) 1353
55. Zhang L., Yu W., He T., Yu J., Caffrey R.E., Dalmasso E.A., Fu S., Pham T., Mei J., Ho J.J., Zhang W., Lopez P., and Ho D.D. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298 (2002) 995